Tag: investment
-
Biopharm Company Raising $40 Million in IPO
Omeros Corporation, a biopharmaceutical company developing drugs that prevent inflammation in surgeries, is raising $40 million in its initial public stock offering.
-
Amgen, Advaxis Partner on Personal Cancer Immunotherapy
Biological drug maker Amgen is licensing precision immunotherapy technology from Advaxis Inc. to develop treatments for cancer.
-
Univ. Spin-Off Develops New Cybersecurity Paradigm
A start-up enterprise from a university is developing a simplified cybersecurity infrastructure for businesses, and raised $2 million in its first funding round
-
Genetic Disease Biotech Gains $55M in Early Funds
A biotechnology start-up developing therapies for genetic diseases through regulation of genetic processes is raising $55 million in its first venture round.
-
Nanotech Imaging Start-Up Raises $3M in Seed Financing
A spin-off enterprise from University of California-Berkeley, developing an imaging technology with magnetic nanoparticles, is raising $3 million in funding.
-
RNA Technology Licensed for Cystic Fibrosis Therapy
Two biotechnology companies are collaborating on treatments for cystic fibrosis that use genetic material to address underlying causes of the inherited disease.
-
Protein Biotech Lands $51.5M in First Venture Round
A spin-off enterprise from Harvard developing therapies that block signaling proteins causing disease is raising $51.5 million its first venture funding round.
-
Animal-Free Leather Company Gains $40M in Venture Funds
A company making leather for consumer goods with tissue engineering and gene-editing from living cells is raising $40 million in its second venture round.
-
Genome Editing Company Adds $38M in Venture Funds
Crispr Therapeutics, a company creating treatments for disease that edit the human genome, is raising another $38 million in its second venture financing round.
-
Immunotherapy Company Raises $70 Million in IPO
Selecta Biosciences, a biotechnology company developing treatments harnessing the immune system, is raising $70 million in its initial public offering.